BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 3, 2026
Breaking News: BioWorld Science 2025 Year in Review
See today's BioWorld Science
Home
» S1P3 receptor at the alveolar-capillary barrier helps drive pulmonary fibrosis
To read the full story,
subscribe
or
sign in
.
Respiratory
S1P3 receptor at the alveolar-capillary barrier helps drive pulmonary fibrosis
Jan. 15, 2026
No Comments
Pulmonary fibrosis is a chronic, progressive respiratory disease in which the normal barrier between alveoli and capillaries is compromised, leading to persistent injury and inflammation of the lung epithelium.
BioWorld Science
Inflammatory
Respiratory